Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2011 3
2012 3
2013 4
2014 8
2015 3
2016 10
2017 6
2018 7
2019 4
2020 7
2021 3
2022 7
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Intravenous Immune Globulin in Dermatomyositis.
Aggarwal R, Charles-Schoeman C, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis C, Schiopu E, Vencovský J, Beckmann I, Clodi E, Bugrova O, Dankó K, Ernste F, Goyal NA, Heuer M, Hudson M, Hussain YM, Karam C, Magnolo N, Nelson R, Pozur N, Prystupa L, Sárdy M, Valenzuela G, van der Kooi AJ, Vu T, Worm M, Levine T; ProDERM Trial Group. Aggarwal R, et al. Among authors: schiopu e. N Engl J Med. 2022 Oct 6;387(14):1264-1278. doi: 10.1056/NEJMoa2117912. N Engl J Med. 2022. PMID: 36198179 Clinical Trial.
Current status of clinical outcome measures in inclusion body myositis: a systematised review.
Roy B, Lucchini M, Lilleker JB, Goyal NA, Naddaf E, Adler B, Alfano LN, Malandraki GA, Focht Garand KL, Mochel D, Badrising U, Machado PM, Pagkatipunan R, Ramdharry G, Wang L, Funaro MC, Schmidt J, Kushlaf H, Schiopu E, Stipancic K, Goyal N, d'Alessandro M, Conticini E, Cruz-Coble B, Lloyd TE; International Myositis Assessment and Clinical Studies (IMACS) Inclusion Body Myositis Scientific Interest Group. Roy B, et al. Among authors: schiopu e. Clin Exp Rheumatol. 2023 Mar;41(2):370-378. doi: 10.55563/clinexprheumatol/ifacv3. Epub 2023 Feb 3. Clin Exp Rheumatol. 2023. PMID: 36762744 Free article. Review.
Ipilimumab induced digital vasculitis.
Padda A, Schiopu E, Sovich J, Ma V, Alva A, Fecher L. Padda A, et al. Among authors: schiopu e. J Immunother Cancer. 2018 Feb 12;6(1):12. doi: 10.1186/s40425-018-0321-2. J Immunother Cancer. 2018. PMID: 29433584 Free PMC article.
Belimumab treatment of adult idiopathic inflammatory myopathy.
Marder G, Quach T, Chadha P, Nandkumar P, Tsang J, Levine T, Schiopu E, Furie R, Davidson A, Narain S. Marder G, et al. Among authors: schiopu e. Rheumatology (Oxford). 2024 Mar 1;63(3):742-750. doi: 10.1093/rheumatology/kead281. Rheumatology (Oxford). 2024. PMID: 37326854 Clinical Trial.
Efficacy of COVID-19 vaccines in patients taking immunosuppressants.
Shen C, Risk M, Schiopu E, Hayek SS, Xie T, Holevinski L, Akin C, Freed G, Zhao L. Shen C, et al. Among authors: schiopu e. Ann Rheum Dis. 2022 Jun;81(6):875-880. doi: 10.1136/annrheumdis-2021-222045. Epub 2022 Feb 23. Ann Rheum Dis. 2022. PMID: 35197265 Free PMC article.
Case series: Monoarticular rheumatoid arthritis.
Sarazin J, Schiopu E, Namas R. Sarazin J, et al. Among authors: schiopu e. Eur J Rheumatol. 2017 Dec;4(4):264-267. doi: 10.5152/eurjrheum.2017.17011. Epub 2017 Oct 25. Eur J Rheumatol. 2017. PMID: 29308281 Free PMC article.
Antinuclear antibody-negative systemic sclerosis.
Salazar GA, Assassi S, Wigley F, Hummers L, Varga J, Hinchcliff M, Khanna D, Schiopu E, Phillips K, Furst DE, Steen V, Baron M, Hudson M, Taillefer SS, Pope J, Jones N, Docherty P, Khalidi NA, Robinson D, Simms RW, Silver RM, Frech TM, Fessler BJ, Molitor JA, Fritzler MJ, Segal BM, Al-Kassab F, Perry M, Yang J, Zamanian S, Reveille JD, Arnett FC, Pedroza C, Mayes MD. Salazar GA, et al. Among authors: schiopu e. Semin Arthritis Rheum. 2015 Jun;44(6):680-6. doi: 10.1016/j.semarthrit.2014.11.006. Epub 2014 Nov 28. Semin Arthritis Rheum. 2015. PMID: 25578738 Free PMC article.
Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes.
Chen X, Affinati AH, Lee Y, Turcu AF, Henry NL, Schiopu E, Qin A, Othus M, Clauw D, Ramnath N, Zhao L. Chen X, et al. Among authors: schiopu e. Diabetes Care. 2022 May 1;45(5):1170-1176. doi: 10.2337/dc21-2213. Diabetes Care. 2022. PMID: 35238899 Free PMC article.
64 results